$TEVA has tons of IFs: - If there is a nationwide settlement - If the CA decision holds on appeal - If the final settlements are drugs, not cash (and long-term) - If the settlements are accomplished in the relative near-term - If the other opioid non-nuisance lawsuits are settled and not financially burdensome - If the NY case (and others) is not adverse - If the price fixing lawsuits can finally be resolved - If the EBITDA from the existing branded and generic drugs allow for significant debt reduction - THEN, Teva might be worth something again and get a half decent PE and share price.notes from user